Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Bellerophon Therapeutics

05/08/2021 20:28

* Bellerophon Therapeutics Inc  BLPH.OQ  reported a quarterly
adjusted loss of 36 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 66 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Bellerophon Therapeutics Inc's reported EPS for the quarter
was a loss of 36 cents​.
* The mean earnings estimate of analysts had risen by about 5.5%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bellerophon Therapeutics Inc shares had fallen by 17.4% this
quarter and lost 40.0% so far this year.
* The company reported a quarterly loss of $3.39 million.
* Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $26.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 07:27 p.m.  ​All
figures in US dollars unless otherwise stated